greeksoup/ stock research

Medtronic (MDT) FY2025 results: revenue $33.5 billion, up 3.6% on the year

Medtronic plc (MDT) reported revenue of $33.5 billion for fiscal 2025, the year ended 25 April 2025, up 3.6% on the year before. Net income was $4.7 billion, up 26.8%, and diluted earnings per share $3.61. The figures are the company's own, from the 10-K it filed with the SEC on 20 June 2025.

Revenue
$33.5 billion
+3.6% on the year
FY2018FY2025
Operating margin
17.8%
15.9% a year earlier
FY2018FY2025
Net income
$4.7 billion
+26.8% on the year
FY2018FY2025
Diluted EPS
$3.61
+30.8% on the year
FY2018FY2025

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2025 · Q2 FY2025 · Q3 FY2025 · Q4 FY2025

Income statement (profit and loss)

$ millionFY2025FY2024FY2023On the yearLast 8 years
Revenue33,53732,36431,227+3.6%
Cost of revenue11,63211,21610,719+3.7%
Gross profit21,90521,14820,508+3.6%
Gross margin65.3%65.3%65.7%
Research and development2,7322,7352,696-0.1%
Selling, general and administrative10,84910,73610,415+1.1%
Operating income5,9555,1445,485+15.8%
Operating margin17.8%15.9%17.6%
Interest expense729719636+1.4%
Pre-tax income5,6284,8375,364+16.4%
Income tax9361,1331,580-17.4%
Effective tax rate16.6%23.4%29.5%
Net income4,6623,6763,758+26.8%
Net margin13.9%11.4%12.0%
Diluted EPS$3.61$2.76$2.82+30.8%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2025FY2024FY2023On the yearLast 8 years
Operating cash flow7,0446,7876,039+3.8%
Capital expenditure1,8591,5871,459+17.1%
Free cash flow5,1855,2004,580-0.3%
Free cash flow margin15.5%16.1%14.7%
Cash from investing-1,937-2,366-3,493
Cash from financing-4,361-4,450-4,960
Depreciation and amortisation2,8612,6472,697+8.1%
Share-based compensation429393355+9.2%
Buybacks3,2352,138645+51.3%
Dividends paid3,5893,6663,616-2.1%
Dividend per share$2.80$2.76$2.72+1.4%
Diluted shares, weighted1,290m1,330m1,333m-3.0%
Shares outstanding at period end1,282m1,311m1,331m-2.2%

Balance sheet

$ millionFY2025FY2024FY2023On the yearLast 8 years
Shareholders' equity48,02450,21451,483-4.4%
Non-controlling interest232206182+12.6%
Debt28,51625,02424,344+14.0%
Operating lease liabilities918840869+9.3%
Finance lease liabilities52.055.057.0-5.5%
Other liabilities13,93813,64214,013+2.2%
Total liabilities and equity91,68089,98190,948+1.9%
Fixed assets6,8376,1315,569+11.5%
Goodwill41,73740,98641,425+1.8%
Intangible assets11,66713,22514,844-11.8%
Investments6,7476,7216,416+0.4%
Cash and equivalents2,2181,2841,543+72.7%
Receivables6,5156,1285,998+6.3%
Inventory5,4765,2175,293+5.0%
Other assets10,48310,2899,860+1.9%
Total assets91,68089,98190,948+1.9%

10-K for the year ended 25 April 2025, filed 20 June 2025: the filing.